Results 31 to 40 of about 55,045 (296)
Репродуктивная эндокринология, 2018 Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary menopausal syndrome and has been shown to prevent bone loss and destruction.
С. А. Шурпяк
doaj +1 more source
Репродуктивная эндокринология, 2020 Climacteric is a physiological transition period in a woman’s life during which the reproductive system involutive processes against the age-related changes are dominated in the body, and characterized by reduction of menstrual and generative function ...
О. О. Єфіменко
doaj +1 more source
Menopause, micronutrients, and hormone therapy [PDF]
The American Journal of Clinical Nutrition, 2005 Micronutrient and herbal/phytochemical supplements are of increasing interest as potential alternatives to using estrogen therapy in treating menopausal symptoms. This article provides an overview of the questionnaires that assess menopausal symptoms and research efforts to better standardize symptom assessment.
openaire +2 more sources
, 1999 Objectives: This questionnaire study compared the patterns of reported coping strategies of women high and low in perceived control over hot flushes. Method: A volunteer sample of 38 women fully completed a postal questionnaire.
Reynolds, F, F. Reynolds
core +1 more source
Menopausal hormone therapy: a course to improve the effectiveness [PDF]
Гинекология, 2017 This publication is devoted to one of the most relevant areas of gynecological practice - menopausal hormone therapy. The information is presented in the form of an analytical review of international studies on the benefits and risks of menopausal ...
A L Unanyan +7 more
doaj
Alternative therapy for the treatment of menopausal disorders: effective ways to correct
Медицинский совет, 2018 Menopausal disorders with varying degrees of severity occur in women due to the development of the estrogen-deficient condition in the peri- and postmenopausal period.
Z. N. Efendieva, A. A. Smetnik
doaj +1 more source
Opportunities for prevention and correction of genitourinary menopausal syndrome [PDF]
Гинекология, 2018 In the manifestation and development of urogenital atrophic processes associated with the onset of menopause, the leading role is played by the growing deficiency of estrogens.
I S Zakharov
doaj +1 more source
Arthritis Care &Research, EarlyView.People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Different effects of oral and transdermal hormone replacement therapies on Factor IX, APC resistance, t-PA, PAI and C- reactive protein - a cross-sectional population survey [PDF]
, 2001 The effects of hormone replacement therapy (HRT) on thrombosis risk, thrombotic variables, and the inflammatory marker C- reactive protein (CRP) may vary by route of administration (oral versus transdermal).
Lowe, G.D.O. +5 more
core
Advanced Science, EarlyView.ABSTRACT Brown and beige adipocytes dissipate energy as heat, yet effective strategies to enhance their mitochondrial efficiency remain limited. Here, we identify Agnuside (AGN) as a selective stabilizer of the complex I assembly factor NDUFAF6. AGN directly binds cytosolic NDUFAF6, suppresses its ubiquitination, prolongs its half‐life, and facilitates
Qingwen Zhao +7 more
wiley +1 more source